Optimizing Arsenic Therapy by Selectively Targeting Leukemia Cells.

Arsenic, in the simple form of arsenic trioxide, is currently marketed for the treatment of acute promyelocytic leukemia. Due to the multifaceted mechanisms of action of arsenic, it has also shown promise in other types of leukemias but is hindered by its toxic effects toward normal cells. This research has aimed to determine whether tumor-homing peptide complexes of arsenic can be designed and developed to strategically target specific cancers.

Anti-cancer Evaluation of Depsides Isolated from Indonesian Folious Lichens: , and .

Cancer is a serious health burden on global societies. The discovery and development of new anti-cancer therapies remains a challenging objective. Although it has been shown that lichen secondary metabolites may be potent sources for new anti-cancer agents, the Indonesian- grown folious lichens, and have not yet been explored.

Alkaloids from the root of Indonesian L.

L. has been used traditionally in Indonesia to treat disease. Phytochemical studies on the alkaloid fractions from the root of L.